Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Certain medications and patient factors increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery, but with careful planning and technique adjustments, complications can be minimized.

Plum-blossom needle therapy shows promise for treating hair loss but needs more research.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Tamsulosin increases the risk of floppy iris during eye surgery.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

There is no strong evidence that chemopreventive agents effectively prevent prostate cancer.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Dutasteride helps reduce heavy drinking, especially for those who drink to cope.

Finasteride helps hair growth in men but can cause side effects like decreased libido.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Finasteride's potential harms are hard to accurately measure.

Minoxidil can treat hair loss with topical, oral, and sublingual options, offering personalized choices.

Oral minoxidil improved hair loss more than oral dutasteride.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Finasteride effectively treats hair loss in men with minimal side effects.

Finasteride may cause sexual side effects like erectile dysfunction, but they are reversible and affect less than 2% of men.

Finasteride works better for hair loss in patients 26 or younger.